Fund Overview of Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Direct - Growth
-
₹165.5 CrAUM
-
₹20.67NAV
-
0.52%Expense Ratio
-
EquityFund Category
Returns of Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Direct - Growth
| Tenure | Absolute(%) | Annualised(%) | Category Average(%) |
|---|---|---|---|
| 3 Months | 2.19% | NA | 6.12% |
| 6 Months | 7.85% | NA | 12.92% |
| 1 Year | -1.75% | -1.75% | 6.04% |
| 2 Years | 39.01% | 17.90% | 24.93% |
| 3 Years | 71.29% | 19.65% | 25.71% |
Asset Allocation
equities
99.76%debt instruments
0.25%Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Direct - Growth is one Equity mutual fund offered by Edelweiss Mutual Fund. Launched on 26 Oct 2020, the fund aims Long Term Capital appreciation. Passive investment in equity and equity related securities replicating the composition of MSCI India Domestic & World Healthcare 45 Index, subject to tracking error. It manages assets worth ₹165.5 crore as on Thu Jul 31, 2025. , with a 52-week NAV range between ₹18.34 and ₹20.88. The expense ratio stands at 0.52%. Fund Manager Manager Education Fund Manager Manager EducationAbout Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Direct - Growth
The portfolio allocation consists of 99.76% in equities, 0.25% in debt instruments. Managed by Amit Vora, it has delivered a return of -1.75% in the last year, a total return since inception of 15.72%.
Key Metrics of Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Direct - Growth
-
Standard Deviation12.40%
-
Sharpe Ratio0.96%
-
Alpha-0.05%
-
Beta0.70%
Fund Details
|
|
Top Performing Mutual Funds
| Fund Names | AUM (Cr) | 1M | 3M | 1Yr | 3Yr | 5Yr |
|---|---|---|---|---|---|---|
Tata India Pharma & Healthcare Fund Regular-growth  |
₹1,339 | -1.01% | -0.31% | -2.45% | 21.59% | 16.66% |
growth is based on 1-month returns of the funds & Top fund are based on 3Y Returns
More funds from Edelweiss Mutual Fund
| Fund Names | AUM (Cr) | 1M | 3M | 6M | 1Yr | 3Yr |
|---|---|---|---|---|---|---|
|
Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Regular - Growth
|
₹166 | 1.76% | 1.92% | 12.53% | 1.58% | 18.59% |
|
Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Regular-idcw
|
₹166 | 1.76% | 1.92% | 12.53% | 1.58% | 18.59% |
|
Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Direct-idcw
|
₹166 | 1.81% | 2.05% | 12.83% | 2.13% | 19.25% |
growth is based on 1-month returns of the fundsMutual Fund Calculator
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
Tax Information
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top Mutual Funds
| Fund Names | AUM (Cr) | NAV | 3Yr | 5Yr | 10Yr |
|---|---|---|---|---|---|
| Tata India Pharma & Healthcare Fund Regular-growth |
₹1,339 | ₹30.46 | 21.59% | 16.66% | - |
| Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Direct - Growth |
₹166 | ₹20.67 | 19.25% | - | - |
Detailed Portfolio
| Stocks | Sector | % of Holding | Value |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | 11.45% | ₹18.96 Cr |
| Max Healthcare Institute Ltd | Healthcare | 6.77% | ₹11.21 Cr |
| Cipla Ltd | Healthcare | 6.14% | ₹10.17 Cr |
| Divi's Laboratories Ltd | Healthcare | 5.51% | ₹9.12 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 5.28% | ₹8.73 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 5.19% | ₹8.59 Cr |
| Eli Lilly Forgn. Eq (lly) | Healthcare | 4.98% | ₹8.24 Cr |
| Johnson & Johnson Ltd. Forgn. Eq (jnj) | Healthcare | 3.31% | ₹5.48 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 3.10% | ₹5.13 Cr |
| Lupin Ltd | Healthcare | 3.08% | ₹5.10 Cr |
| Fortis Healthcare Ltd | Healthcare | 2.94% | ₹4.87 Cr |
| Abbvie Inc Forgn. Eq (abbv) | Healthcare | 2.79% | ₹4.62 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.22% | ₹3.68 Cr |
| Laurus Labs Ltd | Healthcare | 2.14% | ₹3.55 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 2.10% | ₹3.48 Cr |
| Aurobindo Pharma Ltd | Healthcare | 2.08% | ₹3.45 Cr |
| Abbott Laboratories Forgn. Eq (abt) | Healthcare | 1.83% | ₹3.02 Cr |
| Novartis Ag Ads/adr (nvs) | Healthcare | 1.80% | ₹2.99 Cr |
| Zydus Lifesciences Ltd | Healthcare | 1.71% | ₹2.82 Cr |
| Merck & Co Inc (us) Forgn. Eq (mrk) | Healthcare | 1.64% | ₹2.71 Cr |
| Alkem Laboratories Ltd | Healthcare | 1.47% | ₹2.44 Cr |
| Thermo Fisher Scientific Inc Forgn. Eq (tmo) | Healthcare | 1.47% | ₹2.44 Cr |
| Biocon Ltd | Healthcare | 1.46% | ₹2.42 Cr |
| Ipca Laboratories Ltd | Healthcare | 1.44% | ₹2.38 Cr |
| Intuitive Surgical Inc. (usa) Forgn. Eq (isrg) | Healthcare | 1.44% | ₹2.38 Cr |
| Amgen Inc. (usa) Forgn. Eq (amgn) | Healthcare | 1.32% | ₹2.19 Cr |
| Novo Nordisk A/s Forgn. Eq (nvo) | Healthcare | 1.25% | ₹2.06 Cr |
| Gilead Sciences Inc. (usa) Forgn. Eq (gild) | Healthcare | 1.17% | ₹1.93 Cr |
| Stryker Corp Forgn. Eq (syk) | Healthcare | 1.12% | ₹1.86 Cr |
| Gland Pharma Ltd | Healthcare | 1.07% | ₹1.77 Cr |
| Danaher Corporation Forgn. Eq (dhr) | Healthcare | 1.06% | ₹1.76 Cr |
| Vertex Pharmaceuticals Inc. (usa) Forgn. Eq (vrtx) | Healthcare | 0.98% | ₹1.62 Cr |
| Medtronic Forgn. Eq (mdt) | Healthcare | 0.97% | ₹1.60 Cr |
| Narayana Hrudayalaya Ltd | Healthcare | 0.96% | ₹1.59 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 0.94% | ₹1.55 Cr |
| Syngene International Ltd | Healthcare | 0.90% | ₹1.50 Cr |
| Ajanta Pharma Ltd | Healthcare | 0.84% | ₹1.39 Cr |
| Piramal Pharma Ltd | Healthcare | 0.82% | ₹1.36 Cr |
| Global Health Ltd | Healthcare | 0.74% | ₹1.22 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 0.71% | ₹1.18 Cr |
| Regeneron Pharmaceuticals Inc Forgn. Eq (regn) | Healthcare | 0.48% | ₹0.80 Cr |
| Becton Dickinson And Co Forgn. Eq (bdx) | Healthcare | 0.42% | ₹0.70 Cr |
| Iqvia Holdings Forgn. Eq (iqv) | Healthcare | 0.27% | ₹0.45 Cr |
| Agilent Technologies Inc Forgn. Eq (a) | Healthcare | 0.27% | ₹0.45 Cr |
| Others Cblo | Unspecified | 0.25% | ₹0.42 Cr |
| Illumina Inc. (usa) Forgn. Eq (ilmn) | Healthcare | 0.13% | ₹0.22 Cr |
| Cash | Unspecified | 0.00% | ₹0.00 Cr |
| Net Payables | Unspecified | -0.01% | ₹-0.03 Cr |
Top Equity Funds
| Fund Names | NAV | 3Yr | 5Yr | 52 weeks high |
|---|---|---|---|---|
| Tata India Pharma & Healthcare Fund Regular-growth |
₹30.46 | 21.59% | 16.66% | 32.01 |
growth is based on 5Y returns of the funds
Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Direct - Growth
What is the current AUM of Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Direct - Growth?
As of Thu Jul 31, 2025, Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Direct - Growth manages assets worth ₹165.5 crore
How has Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Direct - Growth performed recently?
- 3 Months: 2.19%
- 6 Months: 7.85%
What is the long-term performance of Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Direct - Growth?
- 3 Years CAGR: 19.65%
- Since Inception: 15.72%
What is the portfolio composition of Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Direct - Growth?
Equity: 99.76%, Debt: 0.25%, Others: -0.01%.
Who manages Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Direct - Growth?
Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Direct - Growth is managed by Amit Vora from Edelweiss Mutual Fund.
What is the market-cap allocation of Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Direct - Growth?
Large Cap: 79.34%, Mid Cap: 17.15%, Small Cap: 3.51%.
Which are the top companies Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Direct - Growth has invested in?
- Sun Pharmaceutical Industries Ltd – 11.45% of the fund's portfolio
- Max Healthcare Institute Ltd – 6.77% of the fund's portfolio
- Cipla Ltd – 6.14% of the fund's portfolio
- Divi's Laboratories Ltd – 5.51% of the fund's portfolio
- Apollo Hospitals Enterprise Ltd – 5.28% of the fund's portfolio
Which are the major sectors Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Direct - Growth focuses on?
- Healthcare – 99.76% of the fund's portfolio
- Unspecified – 0.24% of the fund's portfolio
Policybazaar does not endorse rates/returns or recommend any particular insurer, fund house, AMC (Asset Management Company), insurance and mutual fund product.
Please consult your financial advisor for an informed decision.
Past performance may not be indicative of future results.
The information presented on this page is not owned or generated by Policybazaar. The data has been collected from publicly available sources and online research. We do not claim any ownership or guarantee the accuracy, completeness, or timeliness of this information. It is shared solely for the informational purpose of the viewer and should not be considered as financial advice.
Policybazaar is not acting as a financial advisor, broker, or agent for any mutual fund mentioned here.
Mutual fund investments are subject to market risks. Please read all scheme-related documents carefully before investing.
Policybazaar shall not be held responsible or liable for any losses, damages, or decisions made based on the information provided on this page.
For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product. For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product.
For more details on risk factors, terms, and conditions, please read the sales brochure and benefit illustration carefully before concluding a sale.
Policybazaar is a registered Insurance Broker | Registration No. 742, Registration Code No. IRDA/ DB 797/ 19, Valid till 09/06/2024, License category- Direct Broker (Life & General) |CIN: U74999HR2014PTC053454 | Registered Office - Plot No.119, Sector - 44, Gurgaon, Haryana – 122001 |Visitors are hereby informed that their information submitted on the website may be shared with insurers. Product information is authentic and solely based on the information received from the insurers.©️ Copyright 2008-2025 policybazaar.com. All Rights Reserved
^Returns as on 10th Jan’25. Tata AIA Life Top 200 ULIP Fund has delivered 18% returns over the last 10 years. Past performance is not necessarily indicative of future results. This disclaimer is specifically regarding a ULIP fund and is not related to mutual funds. Source: Morningstar.
